Jan Steyaert Named 2022 Jacob and Louise Gabbay Award Winner
GPCR News
Structural basis of GPCR coupling to distinct signal transducers: implications for biased signaling
Amgen to Acquire Chemocentryx for $4 Billion in Cash
Deciphering the signaling mechanisms of β-arrestin1 and β-arrestin2 in regulation of cancer cell...
GPCRs steer G i and G s selectivity via TM5-TM6 switches as revealed by structures of serotonin...
Addex and Indivior Extend GABAB Positive Allosteric Modulator Research Collaboration for...
Gαs and Gαq/11 protein coupling bias of two AVPR2 mutants (R68W and V162A) that cause nephrogenic di
The NPXXY Motif Regulates β-Arrestin Recruitment by the CB1 Cannabinoid Receptor
G protein-coupled receptor 21 in macrophages: An in vitro study
MSX-122: Is an effective small molecule CXCR4 antagonist in cancer therapy?
Fusion protein strategies for cryo-EM study of G protein-coupled receptors
Addex Reports 2022 Half Year and Second Quarter Financial Results and Provides Corporate Update
GPR3 expression in retinal ganglion cells contributes to neuron survival and accelerates axonal...
Diversity and specificity in location-based signaling outputs of neuronal GPCRs
Posttranslational modifications in GPCR internalization
Molecular basis for ligand modulation of the cannabinoid CB 1 receptor
In vivo detection of GPCR-dependent signaling using fiber photometry and FRET-based biosensors
GRK2 in cardiovascular disease and its potential as a therapeutic target
Targeting CXCR1 and CXCR2 receptors in cardiovascular diseases
TAS2R supports odontoblastic differentiation of human dental pulp stem cells in the inflammatory...